Mobile

A blinded-initiation study of medication satisfaction in subjects with schizophrenia treated with paliperidone ER after suboptimal response to oral risperidone

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-004482-18

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to assess the observed change in the Medication Satisfaction Questionnaire (MSQ) score, from baseline to the Week 6 endpoint, when paliperidone ER (6 mg to 12 mg) is administered for at least 4 weeks to subjects with schizophrenia who are suboptimally responsive to risperidone 4 mg to 6 mg.

Critère d'inclusion

  • Schizophrenia

Liens